Entecavir (Baraclude) and Ketamine Therapy | Tovani Health
Baraclude (Entecavir) — Nucleoside reverse transcriptase inhibitor (chronic Hep B)
Verdict at Tovani Health
Fully compatible with KAP.
Entecavir and ketamine have no clinically significant interaction. First-line oral therapy for chronic hepatitis B (alongside tenofovir). High barrier to resistance, well-tolerated long-term. Renally cleared with no significant CYP involvement.
If you take Baraclude regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Baraclude interacts with ketamine
Entecavir is a guanosine analog that inhibits HBV reverse transcriptase after intracellular phosphorylation. Renal clearance. No CYP interaction with ketamine.
What we do at intake
Continue your Hep B regimen.
Bottom line
Entecavir and ketamine have no clinically significant interaction. First-line oral therapy for chronic hepatitis B (alongside tenofovir). High barrier to resistance, well-tolerated long-term. Renally cleared with no significant CYP involvement.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Baraclude (Entecavir) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 23, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.